These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2730687)

  • 41. Relationship between progesterone receptor binding and progestin biological activity.
    Spilman CH; Wilks JW; Campbell JA
    J Steroid Biochem; 1985 Mar; 22(3):289-92. PubMed ID: 3921767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of progestins and antiprogestins on mitochondria in uterine glandular cells in the rat. A quantitative investigation.
    Secchi J; Lecaque D
    Cell Tissue Res; 1984; 238(2):247-52. PubMed ID: 6568878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of antiprogestational steroids.
    Wiechert R; Neef G
    J Steroid Biochem; 1987; 27(4-6):851-8. PubMed ID: 3320563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Target tissue uptake selectivity of three fluorine-substituted progestins: potential imaging agents for receptor-positive breast tumors.
    Pomper MG; Pinney KG; Carlson KE; van Brocklin H; Mathias CJ; Welch MJ; Katzenellenbogen JA
    Int J Rad Appl Instrum B; 1990; 17(3):309-19. PubMed ID: 2341287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bromine- and iodine-substituted 16alpha,17alpha-dioxolane progestins for breast tumor imaging and radiotherapy: synthesis and receptor binding affinity.
    Zhou D; Carlson KE; Katzenellenbogen JA; Welch MJ
    J Med Chem; 2006 Jul; 49(15):4737-44. PubMed ID: 16854080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonsteroidal progesterone receptor ligands. 1. 3-Aryl-1-benzoyl-1,4,5,6-tetrahydropyridazines.
    Combs DW; Reese K; Phillips A
    J Med Chem; 1995 Dec; 38(25):4878-9. PubMed ID: 8523399
    [No Abstract]   [Full Text] [Related]  

  • 47. 6 alpha-[18F]fluoroprogesterone: synthesis via halofluorination-oxidation, receptor binding and tissue distribution.
    Choe YS; Bonasera TA; Chi DY; Welch MJ; Katzenellenbogen JA
    Nucl Med Biol; 1995 Jul; 22(5):635-42. PubMed ID: 7581174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of potential antiprogestogens.
    Ranade VV; Counsell RE
    Steroids; 1976 Jan; 27(1):123-31. PubMed ID: 178072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological activity of 11,19-bridged progestins.
    Schwede W; Fritzemeier KH; Halfbrodt W; Krattenmacher R; Muhn P; Neef G; Ottow E; Schöllkopf K
    Steroids; 1998 Mar; 63(3):166-77. PubMed ID: 9558718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The acute effect of progestational compounds on intact rabbit myometrium.
    SCHOFIELD BM
    J Physiol; 1961 Jun; 157(1):117-23. PubMed ID: 13748429
    [No Abstract]   [Full Text] [Related]  

  • 51. Progestagen nuclear binding sites in the male genital tract of the mouse, studied by autoradiography.
    Schleicher G; Sar M; Bidmon HJ; Stumpf WE
    J Steroid Biochem Mol Biol; 1993 Sep; 46(3):389-93. PubMed ID: 9831488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiprogestins in the induction of labor.
    Chwalisz K; Garfield RE
    Ann N Y Acad Sci; 1994 Sep; 734():387-413. PubMed ID: 7978941
    [No Abstract]   [Full Text] [Related]  

  • 53. Screening of anti-progestagens by receptor studies and bioassays.
    Kloosterboer HJ; Deckers GH; van der Heuvel MJ; Loozen HJ
    J Steroid Biochem; 1988 Oct; 31(4B):567-71. PubMed ID: 3199806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiprogestins in gynecological diseases.
    Goyeneche AA; Telleria CM
    Reproduction; 2015 Jan; 149(1):R15-33. PubMed ID: 25252652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progesterone receptor binding of steroidal and nonsteroidal compounds.
    Neelima MS; Bhaduri AP
    Prog Drug Res; 1986; 30():151-88. PubMed ID: 3544043
    [No Abstract]   [Full Text] [Related]  

  • 56. Synthesis and biological activity of 17-chloro-16(17) unsaturated D-homo antiprogestins.
    Schwede W; Cleve A; Neef G; Ottow E; Stöckemann K; Wiechert R
    Steroids; 1994 Mar; 59(3):176-80. PubMed ID: 8048148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of new compounds for antiprogestational activity.
    Mehrotra PK; Prashad M; Seth M; Bhaduri AP; Kamboj VP
    Indian J Exp Biol; 1979 Dec; 17(12):1317-9. PubMed ID: 161551
    [No Abstract]   [Full Text] [Related]  

  • 58. Ethical considerations concerning the use of anti-progestins.
    Int J Gynaecol Obstet; 1994 Oct; 47(1):81-2. PubMed ID: 7813761
    [No Abstract]   [Full Text] [Related]  

  • 59. Relative binding affinity of various progestins and antiprogestins to a rabbit myometrium receptor.
    Boonkasemsanti W; Aedo AR; Cekan SZ
    Arzneimittelforschung; 1989 Feb; 39(2):195-9. PubMed ID: 2730687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relative binding affinity of antiprogestins ZK 98.299 and ZK 98.734 for progesterone receptors in the endometrium and myometrium of bonnet monkeys.
    Pongubala JM; Elger WA; Puri CP
    J Recept Res; 1987; 7(6):903-20. PubMed ID: 3450874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.